Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Yerba mate (Ilex paraguariensis) contains xanthine alkaloids including caffeine (0.7-1.7%) and high concentrations of polyphenols (178.32 mg/g in extracts) that provide stimulant and antioxidant effects. The polyphenolic compounds demonstrate free-radical scavenging activity with laboratory DPPH IC50 values of 2.52 mg/mL.
Origin & History
Yerba Maté derives from the leaves of Ilex paraguariensis, an evergreen tree native to subtropical South America that grows up to 15 meters tall in Paraguay, Argentina, and Brazil. The ingredient is produced by harvesting, drying, and sometimes aging the leaves, with extraction methods including traditional hot water infusion or modern spray-drying for concentrated extracts.
Research Narrative (Provisional)
The research dossier reveals no specific human clinical trials, RCTs, or meta-analyses with PubMed PMIDs examining yerba maté's effects. While general references note traditional uses for stimulant, antioxidant, antimicrobial, and diuretic effects, controlled clinical trial data is absent from the available literature.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Yerba Maté contains a complex array of bioactive compounds with the following approximate concentrations per 100g dry leaf material: Polyphenols (total): 178.32 mg/g in spray-dried extract, including chlorogenic acids (the dominant phenolic class, 70–150 mg/g dry weight), primarily 5-caffeoylquinic acid (5-CQA), 3-caffeoylquinic acid, and dicaffeoylquinic acid isomers. Flavonoids include quercetin (~0.3–0.7 mg/g), kaempferol (~0.1–0.4 mg/g), and rutin (~0.5–1.2 mg/g). Xanthine alkaloids: caffeine 0.7–1.7% dry weight (~700–1700 mg/100g), theobromine 0.3–0.9% (~300–900 mg/100g), theophylline in trace amounts (~0.05–0.1%). Saponins (ursolic acid and oleanolic acid derivatives): ~3–7% dry weight, contributing bitter taste and emulsifying properties; bioavailability of saponins is limited due to poor intestinal absorption. Minerals: potassium (~400–500 mg/100g brewed), magnesium (~40–70 mg/100g dry), manganese (~2–3 mg/100g dry), phosphorus (~70–90 mg/100g dry), iron (~3–5 mg/100g dry, though bioavailability reduced by polyphenol binding). Vitamins: Vitamin C present in fresh leaf (~20–30 mg/100g) but largely degraded during drying/processing; B vitamins including B1 (thiamine ~0.1 mg/100g), B2 (riboflavin ~0.1–0.2 mg/100g), and niacin (~0.5–1.0 mg/100g). Amino acids: theanine reported in minor quantities; total protein content ~10–15% dry weight in raw leaf. Dietary fiber: ~20–30% dry weight (predominantly insoluble). Chlorogenic acid bioavailability from brewed maté is moderate (~30–40% absorbed in small intestine), with colonic microbial metabolism of unabsorbed fraction producing bioactive metabolites such as caffeic acid and ferulic acid. Fat content is negligible (<1%). Carbohydrates: ~40–50% dry weight, largely structural polysaccharides. A standard brewed serving (1g leaf/100 mL water) delivers approximately 80–120 mg caffeine, 20–50 mg theobromine, and 150–300 mg total polyphenols depending on brew time and temperature.
Reported Mechanism (Provisional)
Yerba mate's xanthine alkaloids (caffeine, theobromine, theophylline) block adenosine receptors in the central nervous system, promoting alertness and reducing fatigue. The high polyphenol content, particularly saponins and chlorogenic acids, scavenges free radicals and exhibits catalase-like enzymatic activity. These compounds also modulate inflammatory pathways by inhibiting pro-inflammatory cytokine production.
Clinical Narrative (Provisional)
Current evidence for yerba mate primarily consists of laboratory antioxidant studies and traditional use documentation rather than controlled human trials. In vitro studies demonstrate significant antioxidant capacity through DPPH assays and polyphenol quantification in various extract preparations. Limited small-scale human studies have examined metabolic effects, but sample sizes are generally under 50 participants with short intervention periods. More robust clinical trials are needed to establish therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.